Literature DB >> 33642419

Orthogonal antibody testing for COVID-19 among healthcare workers in a non-epidemic place and time:Japan's Iwate Prefecture, May 18-31, 2020.

Akihiro Nakamura1, Ryoichi Sato2, Sanae Ando2, Natsuko Oana2, Eiji Nozaki2, Hideaki Endo3, Yoshiharu Miyate4, Jun Soma5, Go Miyata6.   

Abstract

Of the 47 prefectures in Japan, Iwate had the fewest cases of coronavirus disease 2019 (COVID-19), with the first diagnosis officially confirmed on July 28, 2020. A baseline serological survey of COVID-19 antibodies is essential to accurately evaluate an epidemic outbreak. The primary purpose of this study was to determine pre-epidemic prevalence of COVID-19 antibodies among healthcare workers, using two laboratory-based quantitative tests. In addition, a point-of-care (POC) qualitative test, rapid, simple, and convenient for primary care clinics, was compared with the laboratory-based tests. All antibody tests were performed on serum from 1,000 healthcare workers (mean age, 40 ± 11 years) in Iwate Prefectural Central Hospital, May 29-31, 2020. A COVID-19 case was defined as showing positive results in both laboratory-based quantitative tests. None of 1,000 samples had positive results in both of the laboratory immunoassays. The POC test showed positive results in 33 of 1,000 samples (3.3%) (95% confidence interval:2.19-4.41), but no samples were simultaneously positive in both laboratory-based tests. In conclusion, COVID-19 cases were not serologically confirmed by a baseline control study of healthcare workers at our hospital in late May, 2020. Moreover, the POC qualitative test may offer no advantage in areas with very low prevalence of COVID-19, due to higher false-positive reactions compared with laboratory-based quantitative immunoassays.

Entities:  

Keywords:  COVID-19; Iwate; SARS-CoV-2; antibody test; seroprevalence

Mesh:

Substances:

Year:  2021        PMID: 33642419     DOI: 10.5387/fms.2020-21

Source DB:  PubMed          Journal:  Fukushima J Med Sci        ISSN: 0016-2590


  2 in total

1.  Immunoglobulin G Antibodies to SARS-CoV-2 Among Healthcare Workers at a Tertiary Care Center in South India.

Authors:  Aneesh Basheer; Reba Kanungo; Vivian J Ratnam; Ravichandran Kandasamy
Journal:  Cureus       Date:  2022-02-23

2.  Disease Prevalence Matters: Challenge for SARS-CoV-2 Testing.

Authors:  Chin-Shern Lau; Tar-Choon Aw
Journal:  Antibodies (Basel)       Date:  2021-12-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.